FUSIONNER™ TECHNOLOGY
Fusionner technology represents an innovative approach in the field of cannabis-based medicine, using a Self-Emulsifying Drug Delivery Systems (SEDDS) formulation. This revolutionary technology was developed by Entourage Phytolab to optimize the delivery of cannabinoids, improving bioavailability and reducing side effects.
Introduction
The therapeutic efficacy of cannabinoids is often limited by their low water solubility and bioavailability. water and bioavailability. Fusionner seeks to overcome these challenges by using a SEDDS.
SEDDS formulation
The SEDDS formulation consists of oil, surfactants and co-surfactants that self-emulsify. This technology allows cannabinoids to be dispersed into tiny particles, improving their solubility and absorption.
Clinical Benefits
Increased absorption: SEDDS technology facilitates the absorption of cannabinoids, enhancing the therapeutic response.
Reduced side effects: optimizes delivery, making treatment more comfortable for patients.
Greater accessibility: More effective and affordable for a wide range of patients.
Components
- Oil: Lipophilic carrier for cannabinoids.
- Surfactants: facilitates emulsion by increasing solubility.
- Co-surfactants: help stabilize the emulsion.
Clinical Application
Fusionner can be integrated into various therapeutic modalities, including chronic pain, epilepsy, anxiety, among others.
FUSIONNER™ TECHNOLOGY
Fusionner technology, with its SEDDS formulation, offers a significant advance in the administration of cannabinoids. Its potential to increase treatment efficacy, reduce side effects and broaden accessibility to different patients makes it a valuable innovation in the field of cannabis-based medicine.
Doctors and researchers are encouraged to explore this technology, and Entourage Phytolab is available to provide more information and support.
To find out more about integrating Fusionner into your medical practice, contact us.